DSIJ Mindshare

Lupin has received the Establishment Inspection Report (EIR) from the US drug regulator upon completion of inspection of its facility in Tarapur, Maharashtra. The inspection was conducted between August 27 and August 31, 2018 concluded with one observation.

IIFL Holdings Limited through its subsidiary IIFL Securities plans to acquire approximately 15 per cent stake in Trendlyne, which provides an analytics platform for studying stocks. The site is popular among retail investors, analyst and advisors.

Zydus Cadila has received the final USDFA approval for Baclofen Tablets, 10mg and 20mg. The shares of the company, however fell intraday.

Alembic Pharmaceuticals has collected yet another USFDA approval, now for Temazepam Capsules. The shares of the company gained almost 3 per cent intraday. 

Following stocks are close to their 52-week low as at 12.56 p.m. on November 27, 2018.